Detalhe da pesquisa
1.
Clinical trial designs for evaluating and exploiting cancer evolution.
Cancer Treat Rev
; 118: 102583, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37331179
2.
A Phase I Trial of CT900, a Novel α-Folate Receptor-Mediated Thymidylate Synthase Inhibitor, in Patients with Solid Tumors with Expansion Cohorts in Patients with High-Grade Serous Ovarian Cancer.
Clin Cancer Res
; 28(21): 4634-4641, 2022 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35984704
3.
Current and emerging systemic therapies for cutaneous metastatic melanoma.
Expert Opin Pharmacother
; 20(9): 1135-1152, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31025594
4.
Building on the anti-PD1/PD-L1 backbone: combination immunotherapy for cancer.
Expert Opin Investig Drugs
; 28(8): 695-708, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31359805
5.
Corrigendum to "Clinical trial designs for evaluating and exploiting cancer evolution" [Cancer Treat. Rev. 118 (2023) 101583].
Cancer Treat Rev
; 119: 102596, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37419039
6.
A study of 1088 consecutive cases of electrolyte abnormalities in oncology phase I trials.
Eur J Cancer
; 104: 32-38, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30316017
7.
Efficacy of doxorubicin after progression on carboplatin and paclitaxel in advanced or recurrent endometrial cancer: a retrospective analysis of patients treated at the Brazilian National Cancer Institute (INCA).
Med Oncol
; 35(3): 20, 2018 Jan 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-29387971
8.
Neutrophil-lymphocyte ratio kinetics in patients with advanced solid tumours on phase I trials of PD-1/PD-L1 inhibitors.
Eur J Cancer
; 89: 56-63, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29227818
9.
A phase I study of mTOR inhibitor everolimus in association with cisplatin and radiotherapy for the treatment of locally advanced cervix cancer: PHOENIX I.
Cancer Chemother Pharmacol
; 78(1): 101-9, 2016 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-27206639